Double Sequential External Defibrillation in Patients With Atrial Fibrillation Refractory to DC Cardioversion

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT03827915

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
American University of Beirut Medical Center (from the registry)
Registry
  • NCT NCT03827915
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Lebanon (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03827915. Randomized; no masking; primary purpose treatment. Start 2019-01-21 (actual); primary completion 2024-01-21 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Double Sequential External Defibrillation in Patients With Atrial Fibrillation Refractory to DC Cardioversion
Condition
Defibrillators
Condition
Persistent Atrial Fibrillation
Intervention (Device)
Double sequential external defibrillation
Lead sponsor
American University of Beirut Medical Center (class: other)

Record details

Record id
cardio:ct-nct03827915
Content hash
0665afc9e679fcbfc0f0683c3d4c3f7d52eef6f553de7e50608f0885962bf988